dc.contributor.author | Flores-Borja, F | |
dc.contributor.author | Bosma, A | |
dc.contributor.author | Ng, D | |
dc.contributor.author | Reddy, V | |
dc.contributor.author | Ehrenstein, MR | |
dc.contributor.author | Isenberg, DA | |
dc.contributor.author | Mauri, C | |
dc.date.accessioned | 2020-04-30T16:07:27Z | |
dc.date.available | 2020-04-30T16:07:27Z | |
dc.date.issued | 2013-02-20 | |
dc.identifier.citation | : F. Flores-Borja, A. Bosma, D. Ng, V. Reddy, M. R. Ehrenstein, D. A. Isenberg, C. Mauri, CD19+ CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci. Transl. Med. 5, 173ra23 (2013 | en_US |
dc.identifier.issn | 1946-6234 | |
dc.identifier.other | ARTN 173ra23 | |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/63879 | |
dc.description.abstract | The relevance of regulatory B cells in the maintenance of tolerance in healthy individuals or in patients with immune disorders remains understudied. In healthy individuals, CD19+
CD24hiCD38hi B cells suppress CD4+
CD25− T cell
proliferation as well as the release of interferon-g and tumor necrosis factor–a by these cells; this suppression is
partially mediated through the production of interleukin-10 (IL-10). We further elucidate the mechanisms of
suppression by CD19+
CD24hiCD38hi B cells. Healthy CD19+
CD24hiCD38hi B cells inhibited naïve T cell differentiation into T helper 1 (TH1) and TH17 cells and converted CD4+
CD25− T cells into regulatory T cells (Tregs),
in part through the production of IL-10. In contrast, CD19+
CD24hiCD38hi B cells from patients with rheumatoid
arthritis (RA) failed to convert CD4+
CD25− T cells into functionally suppressive Tregs or to curb TH17 development;
however, they maintained the capacity to inhibit TH1 cell differentiation. Moreover, RA patients with active disease have reduced numbers of CD19+
CD24hiCD38hi B cells in peripheral blood compared with either patients with
inactive disease or healthy individuals. These results suggest that in patients with active RA, CD19+
CD24hiCD38hi
B cells with regulatory function may fail to prevent the development of autoreactive responses and inflammation,
leading to autoimmunity. | en_US |
dc.description.sponsorship | This project and F.F.-B. are funded by the Arthritis Research UK Programme grant MP/17707. A.B. is funded by The Nuffield Foundation | en_US |
dc.language.iso | en | en_US |
dc.publisher | American Association for the Advancement of Science | en_US |
dc.relation.ispartof | SCIENCE TRANSLATIONAL MEDICINE | |
dc.rights | All rights reserved | |
dc.subject | regulatory B cells | en_US |
dc.subject | immune disorders | en_US |
dc.subject | T cell–mediated immune responses | en_US |
dc.title | CD19(+)CD24(hi)CD38(hi) B Cells Maintain Regulatory T Cells While Limiting T(H)1 and T(H)17 Differentiation | en_US |
dc.type | Article | en_US |
dc.rights.holder | American Association for the Advancement of Science. | |
dc.identifier.doi | 10.1126/scitranslmed.3005407 | |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000315262000002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 173 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 5 | en_US |
dcterms.dateAccepted | 2013-01-10 | |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |